Shanxi Securities: Sora officially launched the AI video generation tool, which continued to iterate. Shanxi Securities Research Report pointed out that 1) On December 10th, OpenAI officially launched Sora. Compared with the version released by OpenAI in February, the new Sora launched this time added Storyboard, Remix, Re-cut and other functions, which greatly improved the video re-creation ability and optimized the video generation speed and generation method. 2) Since the beginning of this year, domestic enterprises have begun to accelerate the research and development and iteration of AI video generation products, and the product capabilities have been continuously improved and the application scenarios have been continuously broadened. Sora was officially launched, and the video creation ability was significantly improved, and it began to change from a creative tool to a productivity tool. With the continuous iteration of AI video generation tools represented by Sora, its penetration into various application scenarios is expected to accelerate in the future. On the one hand, the application layer suggests focusing on creative, design, education and other multi-modal fields, especially video generation. On the other hand, the demand for computing power in video generation model is significantly higher than that in text, focusing on AI computing power related targets.Kangxinuo said on the interactive platform that the company is promoting the research and development of a variety of innovative vaccines, submitting applications for related matters in accordance with the guiding principles of CDE, and actively communicating and reporting.The 30-year Treasury ETF rose sharply at the opening, hitting a record high. Both "Boshi SSE 30-year Treasury ETF" and "Pengyang China Bond -30-year Treasury ETF" rose by 0.65%.
The first-phase factory construction project of Aidi Precision (Thailand) started. According to Aidi Precision, in order to better lay out the global market, on December 12, Aidi Precision's first overseas manufacturing factory, Aidi Precision (Thailand), officially started construction. The construction project of Aidi Precision (Thailand) Factory, with a total investment of 35 million US dollars, covers an area of 122 mu and a workshop area of about 60,000 square meters. It will be engaged in the production, manufacture and sales of high-end hydraulic components and hydraulic fittings for construction machinery. The first phase of the project is scheduled to be completed and put into operation in October 2025.Pengyue Automobile Development Co., Ltd., a subsidiary of Tucki, was forced to enforce 680,000 yuan. According to the risk information of Tianyan, recently, Guangzhou Pengyue Automobile Development Co., Ltd. and Hunan Chunqiu Engineering Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 684,000 yuan, involving construction contract disputes. The enforcement court is Tianhe District People's Court of Guangzhou. Guangzhou Pengyue Automobile Development Co., Ltd. was established in August 2021, with the legal representative of Zhao Dawu and the registered capital of 1.88 billion RMB. Its business scope includes auto parts retail, tire sales, investment activities with its own funds, electric vehicle charging infrastructure operation, industrial design service and motor vehicle charging sales, etc. It is wholly owned by Guangzhou Xpeng Motors Technology Co., Ltd.Most gold stocks in Hong Kong stocks fell, and Lingbao Gold fell by nearly 5%. As of press time, Lingbao Gold (03330.HK) fell by 4.75%, Zijin Mining (02899.HK) fell by 2.82% and Zhaojin Mining (01818.HK) fell by 2.75%.
Guojin Securities: The warm wind of medical policy comes first, then the progress of innovation going out to sea, and then the opportunity of performance reversal. Guojin Securities Research Report said that the core investment opportunities in the pharmaceutical sector in 25 years will revolve around three logics: 1) innovation going out to sea; 2) demand recovery; 3) Policy expectation reversal. At present, the policy warm wind comes first (the medical track policy continues to warm up, and the overall industry expectation is expected to be optimistic); Then, R&D and innovation will go to sea (innovative drug track will continue to make progress, and it will still be the hottest track in the pharmaceutical sector in 2025, especially it is recommended to pay attention to the clinical data reading and commercialization progress of the first-line target, as well as the fluctuation opportunity of the expected difference of the second-line innovative drugs), and then the performance growth rate is expected to bottom out in the first half of 2025 (but it will take time for this improvement in performance growth rate to come. Considering the current industry communication and historical base, it is expected that 4Q24 and 1Q25 should still be cautiously optimistic.)The T-shaped overpass with the longest and heaviest single span in China successfully turned and crossed Panxi Railway. According to The Paper, on the afternoon of December 11th, after 82 minutes of continuous construction, the T-shaped overpass with the longest and heaviest single span in China turned 52 degrees clockwise from Panxi Railway Vehicle Turning Station to Yangweishao Station under the jurisdiction of Kunming Bureau of China Railway, realizing a "gorgeous turn" and successfully completed the turn across Panxi Railway.Shenzhen started the construction of the first batch of "AI+" medical equipment professional parks. At the 2024 Shenzhen International High Performance Medical Equipment Exhibition and Innovative Medicine Exhibition held on December 12, a number of breakthrough cutting-edge technological achievements and innovative products were unveiled, and more than 200 famous medical equipment enterprises, scientific research institutions and medical institutions from home and abroad gathered to discuss cutting-edge technologies, explore innovative paths of medical equipment and help the high-quality development of the industry. In order to further seize the opportunity of artificial intelligence medical development, accelerate the digital transformation of Shenzhen's biomedical industry, gather a number of characteristic "AI+" medical equipment enterprises, and incubate a number of innovative medical equipment projects, Shenzhen started to build "AI+" medical equipment professional parks in key areas of industrial development. At this exhibition, the construction of the first batch of Shenzhen "AI+" pharmaceutical machinery professional parks, such as Baolong Biomedical Innovation and Development Pilot Zone, Nanshan Zhicheng, Hetao AI+ Biological Professional Park and Yinxing Science and Technology Park, was officially launched. Next, Shenzhen will vigorously improve the development and incubation of new quality productivity in the field of medical equipment, work together to shape the deep integration ecological pattern of "artificial intelligence+medical equipment", and accelerate the development and growth of "AI+" medical equipment industry.
Strategy guide
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14